UBS Maintains Buy on Aemetis, Lowers Price Target to $7.75
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
UBS analyst Manav Gupta maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $8.25 to $7.75.
UBS analyst Manav Gupta maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $8.25 to $7.75.